Vera Health Raises $28.5M Series A for AI Clinical Search

Vera Health, which runs an AI search engine for clinicians, announced a $28.5 million Series A on October 27, 2026. Threshold Ventures led the round, according to the company's announcement. The company says the round brings its total funding to $32 million.

Every reported figure here comes from the company's own announcement, dated October 27, 2026. Where a number is arithmetic rather than reported, it is labelled as such. Each figure is marked in the text, so a reader can see at a glance which numbers the company stated and which were calculated for this article.

How much did Vera Health raise and who invested?

Vera Health raised $28.5 million in a Series A led by Threshold Ventures. The company says Mantis VC and SV Angel also took part, and that existing investors Y Combinator and Gradient increased their investment.

The release's backer logos name five investors: Threshold Ventures, Y Combinator, Gradient, Mantis VC and SV Angel. The release describes Threshold Ventures as the lead, Mantis VC and SV Angel as participants, and Y Combinator and Gradient as existing investors who tripled down.

How much has Vera Health raised in total?

The company says total funding is $32 million, including this round. That figure is cumulative, so it is not the size of the Series A. Total funding is a running sum, and the Series A is already inside it, so adding the two figures together would double count the round.

The implied $3.5 million is a calculation from the two stated totals, not a reported figure. The release does not itemise any earlier round, so anyone who wants that history will need to look beyond this announcement.

What does Vera Health's platform do?

Vera Health runs an AI-powered clinical search engine. The company says it searches more than 60 million peer-reviewed publications, clinical guidelines, consensus statements and drug labels, then writes an answer. It describes the approach as finding the evidence first and writing the answer after.

The order is the substance of the claim. A search engine that retrieves sources before it writes is making a statement about where its answers come from. The company names four kinds of material the search covers:

• peer-reviewed publications
• clinical guidelines
• consensus statements
• drug labels

The company gives one combined figure of more than 60 million across those kinds. It does not break the total down by kind, so the 60 million figure cannot be split between publications, guidelines, consensus statements and drug labels from the release alone. The product description comes from the company's release, and no independent test of the search results is cited here.

How many clinicians use Vera Health?

The company says more than 800,000 clinicians use the platform, and that it has reached clinicians in 190 countries. It also says most of those clinicians found the platform through a colleague. No independent count of users is cited here.

The wording matters. The company says it has reached clinicians in 190 countries, which describes reach rather than a verified count of active users in each country. Its figure of more than 800,000 is a lower bound it chose to state, not an exact count.

What will the $28.5 million be used for?

The company says the funding will support three areas:

• development of its clinical evidence infrastructure
• expansion into additional healthcare markets
• deeper partnerships with medical societies, publishers and health systems

The release gives no timeline, budget split or hiring plan for the three areas, so readers cannot tell how the $28.5 million will be divided among them.

What's still unclear?

• Valuation. The release gives no valuation for the round. A round size alone does not show how much of the company was sold, so no estimate is made here.
• Usage figures. The 800,000 clinician and 190-country figures come from the company. No outside source counts them.
• Earlier funding. The $3.5 million figure is implied arithmetic. The release does not name earlier investors or rounds.
• Weakest point. The round size, lead investor and total all come from the company's own release. No independent report or regulatory filing has been checked against them yet.

How can a reader check a round like this?

Start with the company's own release, then confirm that press coverage repeats the same round size, lead and total. Keep "company announced" separate from "reported by" coverage, and check whether a figure is a single round or a cumulative total. Work through it in this order:

1. Find the primary release and note its date, its lead and its total.
2. Check whether each outlet cites the release or reports separately. Coverage that only cites the release adds little independent confirmation.
3. Compare dates. A report that predates the announcement needs an explanation before it is trusted.
4. Mark each figure as a single round, a cumulative total or arithmetic.

For the second distinction, see Round Size vs Cumulative Funding. For a method that uses a filing alongside the release, see How to Verify a Startup Funding Claim Using SEC Form D and the Company's Own Release. For typical round sizes at this stage, see Seed vs Series A vs Series B: Typical Round Sizes in 2026.